Lisof
Brand Name: Lisof
Generic Name: Ledipasvir + Sofosbuvir
Active
Registration Number
DRP-10828
Dosage Form
Film-Coated Tablet
Issuance Date
December 1, 2021
Expiry Date
December 1, 2026
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength90mg/400mg
PackagingWhite opaque HDPE bottle with white opaque child -
resistant PP cap x 28 tablets (Box of 28 tablets)
Classification
C
Classification
Prescription Drug (RX)
Philippine FDA Classification
Active Ingredients (2)
Complete list of active ingredients in this pharmaceutical product.
LedipasvirActive
Monograph: Ledipasvir
SofosbuvirActive
Monograph: Sofosbuvir